View Older Stories View More Recent Stories
-
Mizuho Reiterates Outperform Rating on Klaviyo Inc (KVYO)
-
Klaviyo Inc (KVYO) PT Lowered to $43 at Stephens
-
Needham Reiterates Buy Rating on Klaviyo Inc (KVYO)
-
Klaviyo launches Marketing Agent and Customer Agent AI tools
-
Morgan Stanley Upgrades Klaviyo Inc (KVYO) to Overweight
-
Klaviyo announces secondary offering of 6.5 million shares by Summit Partners
-
Klaviyo Inc (KVYO) PT Raised to $46 at TD Cowen as 'Up-Market Momentum Continues'
-
Klaviyo Inc (KVYO) PT Raised to $55 at Piper Sandler on Higher Estimates
-
Klaviyo Inc (KVYO) PT Raised to $46 at Benchmark
-
Klaviyo Inc (KVYO) PT Raised to $42 at Stifel
-
Cantor Fitzgerald Reiterates Overweight Rating on Klaviyo Inc (KVYO)
-
Klaviyo, Inc. (KVYO) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
-
Benchmark Reiterates Buy Rating on Klaviyo Inc (KVYO)
-
Klaviyo launches AI shopping assistant in public beta
-
Klaviyo Inc (KVYO) PT Lowered to $40 at Stifel
-
TD Cowen's Best Smidcap Ideas 2025
-
Cantor Fitzgerald Starts Klaviyo Inc (KVYO) at Overweight
-
Klaviyo (KVYO) Launches Proposed Secondary Share Offering
-
Klaviyo Inc (KVYO) PT Raised to $44 at Benchmark
-
Klaviyo Inc (KVYO) PT Lowered to $45 at Stifel
-
Truist Reiterates Buy Rating on Klaviyo Inc (KVYO) After 'A Strong 1Q With Upside'
-
Klaviyo Inc (KVYO) PT Raised to $35 at Scotiabank
-
Klaviyo Inc (KVYO) PT Lowered to $45 at Canaccord Genuity
-
KeyBanc on Klaviyo Inc (KVYO): 'Uncertainty Embedded and Guidance Still Heading Higher'
-
Klaviyo, Inc. (KVYO) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY25 Revenue Guidance
-
Klaviyo Inc (KVYO) PT Raised to $165 at Benchmark
-
Klaviyo Inc (KVYO) PT Lowered to $40 at Truist Securities
-
Needham Reiterates Buy Rating on Klaviyo Inc (KVYO)
-
Klaviyo Inc (KVYO) PT Raised to $54 at Benchmark
-
Klaviyo Inc (KVYO) PT Raised to $54 at Stifel
-
Klaviyo Inc (KVYO) PT Raised to $55 at TD Cowen Following 'Biggest Beat Since IPO'
-
Klaviyo Inc (KVYO) PT Raised to $54 at Cantor Fitzgerald
-
Klaviyo Inc (KVYO) PT Raised to $55 at Truist, Reflecting 'Higher L-T Growth Estimates'
-
Klaviyo (KVYO) Announces the Only CRM Built For B2C
-
Klaviyo Inc (KVYO) PT Raised to $53; Piper Sandler are 'Buyers on Weakness'
-
Klaviyo Inc (KVYO) PT Raised to $60 at Loop Capital
-
Klaviyo Inc (KVYO) PT Raised to $55 at KeyBanc; 'This Is on the Shortlist of Premium Growers'
-
Klaviyo Inc (KVYO) PT Raised to $52 at Mizuho
-
Klaviyo Inc (KVYO) PT Raised to $50 at Canaccord Genuity
-
Klaviyo Inc (KVYO) PT Raised to $56 at Needham
-
After-hours movers: Carvana, Klaviyo, NerdWallet, BioMarin Pharma, and more
-
Klaviyo, Inc. (KVYO) Misses Q4 EPS by 5c, Beats on Revenue; Offers FY25 Revenue Guidance
-
Klaviyo Inc (KVYO) PT Raised to $51 at Benchmark
-
Klaviyo Inc (KVYO) PT Raised to $45 at KeyBanc on 'Strong Momentum'
-
Klaviyo Inc (KVYO) PT Raised to $46 at Needham
-
Klaviyo Inc (KVYO) PT Raised to $45 at Loop Capital
-
Klaviyo Inc (KVYO) PT Raised to $45 at Baird
-
Klaviyo Inc (KVYO) PT Raised to $47 at Cantor Fitzgerald
-
Klaviyo, Inc. (KVYO) Tops Q3 EPS by 6c; offers outlook
-
Stifel Starts Klaviyo Inc (KVYO) at Buy

